HVD Policy Task Force Comments on CMS’s Proposed National Coverage Decision for T-TEER
Dear Administrator Oz, As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including...
HVV Disease Policy Task Force Paper
Dear Administrator Brooks-LaSure, As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including...
Heart Valve Disease Policy Task Force Submitted Letter to CMS Thanking the Opportunity to Comment on the NCA Tracking Sheet About the TriClip
Dear Administrator Brooks-LaSure, As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including...
Comment on CMS Coverage Policy for Transcatheter Tricuspid Valve Repair – TTVR
Dear Administrator Brooks-LaSure, As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including...
HVV-US Joins 28 Organizations on Letter to Administration about CED Language in White House Initiative
Heart Valve Voice US joined Society for Women’s Health Research and 27 organizations on letter to the Centers for Medicare...
HVD Policy Task Force Comments on FDA’s Review of the PMA for the TriClip G4 System
Dear Dr. Awojope and members of the Circulatory System Devices Panel of the Medical Devices Advisory Committee, While signatories to...
HVD Policy Task Force Comments on MCIT Repeal
Dear Administrator Brooks-LaSure: Heart Valve Voice US is submitting these comments on behalf of the Heart Valve Disease PolicyTask Force,...